Safety of conventional drugs and biologic agents for Rheumatoid Arthritis

A. Amoroso, A. Gigante, C. Gianni, D. Amoroso, D. Zennaro*, S. Galluzzo, D. Caccavo**

Dpt. of Clinical Medicine, University of Rome “La Sapienza” – Rome (Italy)
* Dpt. of Internal Medicine, Campus Bio-Medico University – Rome (Italy)
** Dpt. of Clinical Medicine, Immunology and Infectious Diseases, University of Bari (Italy)

---

• Rheumatology

Abstract. – While initial researches documented that Rheumatoid Arthritis (RA) patients who took biologic agents had decreased symptoms with those receiving traditional treatment, safety of the drugs remains a concern. The Authors in this paper review the safety of the RA new therapeutic approach utilizing biological agents and compare it with the safety of conventional disease-modifying anti-rheumatic drugs (DMARDs).